Tag: GOSH UCL base-editing trial
-
Base Editing Beats ‘Incurable’ Leukemia
Revolutionary base-editing gene therapy achieves 82% remission in ‘incurable’ leukemia. 63% disease-free after 3 years. Discover this breakthrough.
Revolutionary base-editing gene therapy achieves 82% remission in ‘incurable’ leukemia. 63% disease-free after 3 years. Discover this breakthrough.